/ /

Cornea

Re-bubbling cases show a higher endothelial cell loss post-DMEKAnalyses of data from 293 eyes undergoing uncomplicated Descemet membrane endothelial keratoplasty (DMEK) show that endothelial cell loss is greater in eyes that undergo a single re-bubbling for graft separation. The study, however, does not establish a causal association.
Updated classification gives order to corneal dystrophy
Updated classification gives order to corneal dystrophyAn updated classification of corneal dystrophies will help clinicians with properly differentiating and naming the disorders.
Photoactivation holds promise for keratitis treatment
Photoactivation holds promise for keratitis treatmentThe same photoactivation process used in collagen cross-linking for keratoconus can kill bacteria without the need for the oxygen responsible for the biomechanical effects, potentially pointing toward better treatments for keratitis, according to Olivier Richoz, MD, PhD.
Managing progressive keratoconus with the triple procedureFindings from a study undertaken at Dr Lovisolo’s practice indicate that in carefully-selected patients, a triple procedure, comprising Keraring implantation followed by accelerated CXL and topo-guided ablation can provide significant functional improvement in cases of progressive keratoconus.
Surgeons weigh femtosecond features, factors for informed decisionsFemtosecond lasers differ in their indications, energy delivery parameters, and hardware features. Understanding the implications of these factors will enable an objective assessment of the available technology.
Role of anti-VEGF for cornea, ocular surface disease still emergingEvidence for assessing the efficacy and safety of anti-vascular endothelial growth factor (VEGF) agents for treating corneal and ocular surface disease is accumulating. However, there is clearly a need for more research to define if, when, and how this therapy should be used, said Anat Galor, MD.